Spire Healthcare Group (CHIX:SPIL) Debt-to-EBITDA : 5.50 (As of Dec. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Spire Healthcare Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Spire Healthcare Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £102 Mil. Spire Healthcare Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was £1,155 Mil. Spire Healthcare Group's annualized EBITDA for the quarter that ended in Dec. 2023 was £229 Mil. Spire Healthcare Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 5.50.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Spire Healthcare Group's Debt-to-EBITDA or its related term are showing as below:

CHIX:SPIl' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -22.55 Med: 5.88 Max: 11.31
Current: 5.47

During the past 13 years, the highest Debt-to-EBITDA Ratio of Spire Healthcare Group was 11.31. The lowest was -22.55. And the median was 5.88.

CHIX:SPIl's Debt-to-EBITDA is ranked worse than
76.12% of 423 companies
in the Healthcare Providers & Services industry
Industry Median: 2.63 vs CHIX:SPIl: 5.47

Spire Healthcare Group Debt-to-EBITDA Historical Data

The historical data trend for Spire Healthcare Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Spire Healthcare Group Debt-to-EBITDA Chart

Spire Healthcare Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

6.29

-22.55

6.91

6.34

5.47

Spire Healthcare Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial															7.09	6.11	6.46	5.15	5.50

Competitive Comparison of Spire Healthcare Group's Debt-to-EBITDA

For the Medical Care Facilities subindustry, Spire Healthcare Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Spire Healthcare Group's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Spire Healthcare Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Spire Healthcare Group's Debt-to-EBITDA falls into.

Spire Healthcare Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Spire Healthcare Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(101.8	+	1155.2)	/	229.7
	=	5.47

Spire Healthcare Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(101.8	+	1155.2)	/	228.6
	=	5.50

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Spire Healthcare Group (CHIX:SPIl) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Spire Healthcare Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Spire Healthcare Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Spire Healthcare Group (CHIX:SPIL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Spire Healthcare Group PLC (CHIX:SPIl) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

SPI:UK S00:Germany

Address

3 Dorset Rise, London, GBR, EC4Y 8EN

Website

https://www.spirehealthcare.com

Spire Healthcare Group PLC is an independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics. It is a private provider, by volume, of knee and hip operations in the United Kingdom. The Group is a well-located and scalable hospital have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance providers. It treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

Spire Healthcare Group (CHIX:SPIL) Headlines

No Headlines